Colorectal Cancer Stem Cells and Targeted Agents
Preprint
- 17 October 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Once discovered, cancer stem cells have become a hot topic in the research of cancer therapy. These cells possess stem cell-like self-renewal and differentiation capacities and are important factors that dominate cancer metastasis, therapy- resistance and recurrence. What's worse, their own characteristics make them difficult to be eliminated. Colorectal cancer is the third most common cancer and the second leading cause of cancer death worldwide. Targeting colorectal cancer stem cells (CRCSCs) can inhibit colorectal cancer metastasis, enhance therapeutic efficacy, and reduce recurrence. Here, we introduced the origin, marker proteins, identification, cultivation and research techniques of CRCSCs, summarized the signaling pathways that regulate the stemness of CRCSCs, such as Wnt, JAK/STAT3, Notch, and Hh signaling pathway. In addition to these, we also reviewed anti-CRCSC drugs targeting signaling pathways,markers,and other regulators in recent years. These will help researchers gain insight into the current agents targeting to CRCSCs, explore new cancer drugs, and propose potential therapy.Keywords
All Related Versions
This publication has 110 references indexed in Scilit:
- Emerging agents that target signaling pathways to eradicate colorectal cancer stem cellsCancer Communications, 2021
- Colorectal Cancer Stem Cell States Uncovered by Simultaneous Single‐Cell Analysis of Transcriptome and TelomeresAdvanced Science, 2021
- Advances in Liver Cancer Stem Cell Isolation and their CharacterizationStem Cell Reviews and Reports, 2021
- Enrichment of cancer stem cells by agarose multi-well dishes and 3D spheroid cultureCell and tissue research, 2018
- Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β‐catenin pathwayPhytotherapy Research, 2018
- Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cellsCancer Medicine, 2016
- IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial-Mesenchymal Transition and Stemness Maintenance in Colorectal CancerStem Cells, 2016
- Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activityTumor Biology, 2016
- CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expressionJournal of Cancer Research and Clinical Oncology, 2014
- CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potentialClinical & Experimental Metastasis, 2010